[EN] AZA-CYLIC INDOLE- 2 -CARBOXAMIDES AND METHODS OF USE THEREOF<br/>[FR] INDOLE-2-CARBOXAMIDES AZA-CYLIQUES ET PROCÉDÉS D'UTILISATION DE CEUX-CI
申请人:ABBOTT LAB
公开号:WO2009158375A1
公开(公告)日:2009-12-30
The invention relates to aza-cyclic indole-2-carboxamide derivatives, compositions comprising such compounds, and methods of preventing or treating conditions and disorders using such compounds and compositions.
The present invention relates to compounds that are a non-nucleoside reverse transcriptase inhibitors, and to processes for the preparation and use of the same. Specifically, the present invention includes methods of using such compounds in the treatment of human immunodeficiency virus infection.
Re-engineering of the Duocarmycin Structural Architecture Enables Bioprecursor Development Targeting CYP1A1 and CYP2W1 for Biological Activity
作者:Helen M. Sheldrake、Sandra Travica、Inger Johansson、Paul M. Loadman、Mark Sutherland、Lina Elsalem、Nicola Illingworth、Alexander J. Cresswell、Tristan Reuillon、Steven D. Shnyder、Souren Mkrtchian、Mark Searcey、Magnus Ingelman-Sundberg、Laurence H. Patterson、Klaus Pors
DOI:10.1021/jm4000209
日期:2013.8.8
A library of duocarmycin bioprecursors based on the CPI and CBI scaffolds was synthesized and used to probe selective activation by cells expressing CYP1A1 and 2W1, CYPs known to be expressed in high frequency in some tumors. Several CPI-based compounds were pM-nM potent in CYP1A1 expressing cells. CYP2W1 was also shown to sensitize proliferating cells to several compounds, demonstrating its potential as a target for tumor selective activation of duocarmycin bioprecursors.
US8304419B2
申请人:——
公开号:US8304419B2
公开(公告)日:2012-11-06
NOVEL AZA-CYCLIC INDOLE-2-CARBOXAMIDES AND METHODS OF USE THEREOF
申请人:Gopalakrishnan Murali
公开号:US20100035862A1
公开(公告)日:2010-02-11
The invention relates to aza-cyclic-indole-2-carboxamide derivatives, compositions comprising such compounds, and methods of preventing or treating conditions and disorders using such compounds and compositions.